CSS
BDTX icon

Cubist Systematic Strategies’s Black Diamond Therapeutics BDTX Stock Holding History

Cubist Systematic Strategies’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-53,383
Closed -$114K – 2865
2024
Q4 		$114K Buy
+53,383
New +$153K ﹤0.01% 2688
2024
Q2 		– Sell
-43,699
Closed -$222K – 2996
2024
Q1 		$222K Buy
43,699
+28,781
+193% +$116K ﹤0.01% 3032
2023
Q4 		$41.9K Buy
+14,918
New +$35K ﹤0.01% 3290
2023
Q3 		– Sell
-23,210
Closed -$117K – 3345
2023
Q2 		$117K Buy
+23,210
New +$47.4K ﹤0.01% 2966
2022
Q4 		– Sell
-15,973
Closed -$27K – 4244
2022
Q3 		$27K Buy
15,973
+169
+1% +$521 ﹤0.01% 4206
2022
Q2 		$39K Buy
15,804
+3,244
+26% +$7.54K ﹤0.01% 4131
2022
Q1 		$35K Sell
12,560
-19,645
-61% -$71.7K ﹤0.01% 3426
2021
Q4 		$172K Buy
32,205
+5,667
+21% +$39.6K ﹤0.01% 3077
2021
Q3 		$225K Sell
26,538
-66,444
-71% -$656K ﹤0.01% 2524
2021
Q2 		$1.13M Buy
92,982
+72,493
+354% +$1.43M 0.01% 1475
2021
Q1 		$497K Buy
20,489
+1,426
+7% +$38.5K 0.01% 1957
2020
Q4 		$611K Buy
+19,063
New +$626K 0.01% 1671
2020
Q3 		– Sell
-5,475
Closed -$231K – 2485
2020
Q2 		$231K Buy
+5,475
New +$202K ﹤0.01% 1970

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Cubist Systematic Strategies's BDTX Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Black Diamond Therapeutics (BDTX) in Q1 2025, closing a stake of 53,383 shares — an estimated $114K sold.

Cubist Systematic Strategies first reported a position in BDTX in Q2 2020 and held it in 13 quarters. The position peaked at $1.13M in Q2 2021. 84 funds tracked by Wall St. Rank hold BDTX as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Black Diamond Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 53,383 Black Diamond Therapeutics shares in Q1 2025, an estimated $114K.
  • Cubist Systematic Strategies first reported a position in Black Diamond Therapeutics in Q2 2020 and held it in 13 quarters.
  • Cubist Systematic Strategies's Black Diamond Therapeutics position peaked at $1.13M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.